Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs low dose vitamin D on postprandial leukocyte activation and vascular function in overweight/obese women
2013-001948-60Phase 4Active
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vitamin d in cardiac event risk, obesity and Overweight (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Postprandial leukocyte activation marker CD11b. Started Sep 2013; status: active.
02
Drugs
vitamin d
03
Conditions
cardiac event riskobesityOverweight
Beyond the preview
Go deeper on 2013-001948-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001948-60.